Echo Therapeutics (ECTE) Misses Q2 EPS by 8c

Echo Therapeutics (NASDAQ: ECTE) reported Q2 EPS of ($0.31), $0.08 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $19.1 million, versus $22.56 million reported last year.

For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Diana Shipping drops bid for Genco after price demands spike to $36.91
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c